Nepal

in page functions
[French]
Total population (2016) 28,850,639
Birth cohort (2016) 577,535
Surviving Infants (surviving to 1 year per year, 2016) 561,632
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 29/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 36/1000
World Bank Index, IDA (2012) 3.29
Co-financing status (2016) Initial self-financing
No. of districts/territories (2015) 75

Gavi support for Nepal

Type of support

Approvals

2001-2020 (US$)
(22 Jul 2016)

Commitments

2001-2020 (US$)
(22 Jul 2016)

Disbursements

2000-2016 (US$)
(22 Jul 2016)

% Disbursed

(22 Jul 2016)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Cash Support (CASHSUPP) $199,000 $224,000 $199,000 100%
Health system strengthening (HSS 1) $8,667,000 $8,667,000 $8,667,000 100%
Health system strengthening (HSS 2) $14,483,745 $14,483,745 $14,483,745 100%
Health system strengthening (HSS 3) $15,660,000 $36,540,000
HepB mono (NVS) $1,870,980 $1,870,980 $1,870,980 100%
HPV Demo (NVS) $303,500 $303,500 $170,771 56%
Immunisation services support (ISS) $3,312,520 $3,312,520 $3,312,520 100%
Injection safety support (INS) $1,151,893 $1,151,893 $1,151,893 100%
IPV (NVS) $3,324,988 $3,324,988 $2,731,976 82%
JEV (NVS) $1,921,000 $1,921,000 $2,359,390 123%
JEV - Operational costs (OPC) $2,374,000 $2,374,000 $2,374,000 100%
Measles (NVS) $739,500 $739,500 $368,784 50%
Penta (NVS) $36,646,206 $36,646,206 $35,413,185 97%
Pneumo (NVS) $16,948,500 $16,948,500 $19,788,972 117%
Tetra DTP-HepB (NVS) $8,690,385 $8,690,385 $8,690,385 100%
Vaccine Introduction Grant (VIG) $2,638,000 $2,638,000 $2,638,000 100%
Total $118,931,218 $139,836,218 $104,220,601

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Nepal DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2015)

Grade of confidence


N/A
DTP3 - Official country estimates (2015) 91%
M:F sex ratio at birth (2016) 1.07
Household survey: DTP3 coverage for male (2010) 92.10%
Household survey: DTP3 coverage for female (2010) 91.30%
Household survey: Last DTP3 survey (2010) 92%
% districts achieving > 80% DTP3 coverage (2015) 87%
% districts achieving < 50% DTP3 coverage (2015) 0%
MCV WHO/UNICEF estimates (2015) 85%

Breakdown of support

Non-vaccine support Vaccine support
31% 69%
$32,826,158 $71,394,439

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Nepal

30 June 2016

Gavi default item

Gavi Board reappoints WHO's Flavia Bustreo as vice-chair

Board also confirms appointment of four new members and two alternates.

29 June 2016

Making numbers count: fighting pneumonia in Nepal

Clinical research funded by Gavi partners at Patan Hospital in Kathmandu is helping shape Nepal’s immunisation policy against its biggest child killer: pneumonia. This video shows how disease burden and impact studies at Patan have guided the national introduction of Haemophilus influenzae type b and pneumococcal vaccines, which protect children against the two main causes of pneumonia.

03 December 2015

Shaken not destroyed - how Nepal's immunisation system survived an earthquake

Within days of last April's devastating earthquake, Nepal resumed regular immunisation services. From a Kathmandu hospital to clinics in the Himalayas, Nepalese on the front-lines of the national health system tell their stories of a remarkable recovery and show why vaccination is going from strength to strength in the mountain kingdom.

close icon

modal window here